Used primarily in the pharmaceutical industry as an intermediate in the synthesis of bioactive compounds, particularly those targeting central nervous system disorders. Its structure supports the development of potent ligands for neurological receptors, making it valuable in drug discovery for anxiolytic and anticonvulsant agents. The compound's halogen and trifluoromethyl groups enhance binding affinity and metabolic stability, which are critical for optimizing pharmacokinetic properties in lead compounds. It is also explored in research settings for developing novel heterocyclic systems with potential antimicrobial and anti-inflammatory activities.